GFAP and Alzheimer disease: Similar to CSF GFAP, elevated plasma GFAP concentrations have been observed in a variety of neurodegenerative and non-neurodegenerative neurological conditions, including AD (Mayer et al., 2013; Elahi et al., 2020; Heller et al., 2020; van Ballegoij et al., 2020).